Faecal Immunochemical Testing (FIT) Service for NHS Shropshire, Telford and Wrekin ICB

This Invitation to Tender provides information pertaining to the procurement of a Faecal Immunochemical Test (FIT) Service. The purpose of this procurement is to secure a Service Provider to deliver a Faecal Immunochemical Test (FIT) Service for service users within the County of Shropshire.

The Faecal Immunochemical Test (FIT) service will include both 2 week wait and non 2 week wait (2WW) activity in line with NICE NG12 guidance. The FIT service is requested by Primary Care and there is the requirement to communicate results directly to the secondary care service at Shrewsbury and Telford NHS Trust. The service includes the supply of tests, analysis of samples and communicating the results.

The aim of this service is to reduce mortality from bowel cancer for patients registered with a GP in the Shropshire, Telford and Wrekin area. This will be achieved by offering FIT to patients who in the assessment of their GP:

- Do not meet the criteria for a referral under a 2WW Cancer pathway but who require further investigation. - Meet the criteria for urgent suspected lower GI cancer referral. This is to ensure that the referral is accompanied by a faecal immunochemical test (FIT) result, to be used as part of the GP's decision on whether to refer patients.

STW ICB is committed to develop and deliver world class outcomes in Cancer care and treatment for the population.

This ambitious plan requires local health care systems to work collaboratively to implement changes which will bring about significant improvements in the lives of people diagnosed with cancer and enable more people to live full lives beyond cancer.

Currently more than 385,000 people in the UK are diagnosed with cancer each year

- Approximately 3,570 people in Shropshire, Telford & Wrekin are diagnosed with cancer each year. - There is an estimated 50,000 people living with and beyond cancer in Shropshire, Telford & Wrekin and this is predicted to rise. - Macmillan estimate there are 3 million people living with cancer and this is set to increase to 4 million by 2023, and 5.3 million by 2040.

It is envisaged that this service would be live for the period of 3 years with the option to extend up to a period of 24 month. The Authority reserves the right to update the service specification to align with any subsequent national updates at any time throughout the Contract period. The estimated total overall value is £2,303,789.00 including the 24 months optional extension (approx.£460,757.00 per annum).

The NHS Standard Contract Terms and Conditions shall apply.

Additional information: NHS Midlands and Lancashire CSU are conducting this procurement exercise on behalf of another NHS body with whom the successful bidder(s) will enter into a contract with for the supply of the services.

The contract conditions will be set out in the Invitation to Tender. Further details will be made available via documentation and information released during the course of the tender process.

This exercise will be conducted on the Midlands and Lancashire CSU portal ref itt_977 at https://mlcsu.bravosolution.co.uk (i) Candidates should register on the portal at https://mlcsu.bravosolution.co.uk (registration and use of the website is free of charge). If your organisation has registered previously, you do not need to reregister; (ii) Once registered, candidates must submit your reply on the website and by email by the deadline stated. For technical support in submitting your expression of interest contact the Bravo Solution Helpdesk on +448003684850 or E-mail: [email protected].

Light Touch Regime' services: This procurement is for clinical services which are Light Touch Regime Services for the purpose of the Public Contracts Regulations 2015 as specified in Schedule 3 of the regulations ('Regulations'). Accordingly, the contracting authorities are only bound by those parts of the regulations detailed in Chapter 3 Particular Procurement Regimes Section 7. The contracting authorities are not voluntarily following any other part of the Regulations.

As the ICB is a relevant body for the purpose of the National Health Service (Procurement, Patient Choice and Competition) (No. 2) Regulations 2013 these Regulations also apply to this procurement.